<SEC-DOCUMENT>0001157523-18-002609.txt : 20181219
<SEC-HEADER>0001157523-18-002609.hdr.sgml : 20181219
<ACCEPTANCE-DATETIME>20181219140505
ACCESSION NUMBER:		0001157523-18-002609
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20181219
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20181219
DATE AS OF CHANGE:		20181219

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			USANA HEALTH SCIENCES INC
		CENTRAL INDEX KEY:			0000896264
		STANDARD INDUSTRIAL CLASSIFICATION:	MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
		IRS NUMBER:				870500306
		STATE OF INCORPORATION:			UT
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35024
		FILM NUMBER:		181243108

	BUSINESS ADDRESS:	
		STREET 1:		3838 WEST PARKWAY BLVD.
		CITY:			SALT LAKE CITY
		STATE:			UT
		ZIP:			84120-6336
		BUSINESS PHONE:		8019547100

	MAIL ADDRESS:	
		STREET 1:		3838 WEST PARKWAY BLVD.
		STREET 2:		3838 WEST PARKWAY BLVD.
		CITY:			SALT LAKE CITY
		STATE:			UT
		ZIP:			84120-6336

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	USANA INC
		DATE OF NAME CHANGE:	19930125
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>a51916885.htm
<DESCRIPTION>USANA HEALTH SCIENCES, INC. 8-K
<TEXT>
<html>
  <head>
    <title></title>
<!--Copyright 2018 Business Wire, a Berkshire Hathaway company.-->
<!--All rights reserved www.businesswire.com-->
  </head>
  <body style="font-family: Times New Roman; font-size: 10pt">
    <p style="text-align: center">
      <br>
      <font style="font-size: 14pt; font-family: Times New Roman"><b>UNITED
      STATES</b></font><br><br><font style="font-size: 14pt; font-family: Times New Roman"><b>SECURITIES
      AND EXCHANGE COMMISSION</b></font><br><br><font style="font-size: 12pt; font-family: Times New Roman"><b>WASHINGTON,
      D.C. 20549</b></font><br><font style="font-size: 12pt; font-family: Times New Roman">______________</font><br>
    </p>
    <p style="text-align: center">
      <font style="font-size: 14pt; font-family: Times New Roman"><b>FORM 8-K</b></font><br><font style="font-size: 12pt; font-family: Times New Roman">______________</font><br>
    </p>
    <p style="text-align: center">
      <font style="font-size: 12pt; font-family: Times New Roman"><b>CURRENT
      REPORT</b></font><br><br><font style="font-size: 10pt; font-family: Times New Roman">Pursuant
      to Section 13 or 15(d) of</font><br><br>t<font style="font-size: 10pt; font-family: Times New Roman">he
      Securities Exchange Act of 1934</font><br><br><font style="font-size: 10pt; font-family: Times New Roman">Date
      of Report (Date of Earliest Event Reported):</font><br><font style="font-size: 10pt; font-family: Times New Roman">December
      19, 2018</font><br><br><font style="font-size: 24pt"><b>USANA HEALTH
      SCIENCES, INC.</b></font><br><font style="font-size: 10pt; font-family: Times New Roman">(Exact
      name of registrant as specified in its charter)</font><br><br>Utah<br>(State
      or other jurisdiction of incorporation)<br><br>
    </p>
    <div style="text-align:center">
    <table cellspacing="0" style="font-size: 10pt; margin-left:auto;margin-right:auto; width: 100%; margin-bottom: 10.0px; font-family: Times New Roman">
      <tr>
        <td valign="bottom" style="white-space: nowrap; padding-left: 0.0px; padding-right: 0.0px; text-align: center; width: 40%">
          <p style="margin-top: 0px; margin-bottom: 0px">
            001-35024
          </p>
        </td>
        <td style="width: 20%">
          &#160;
        </td>
        <td valign="bottom" style="white-space: nowrap; padding-left: 0.0px; padding-right: 0.0px; text-align: center; width: 40%">
          <p style="margin-top: 0px; margin-bottom: 0px">
            87-0500306
          </p>
        </td>
      </tr>
      <tr>
        <td valign="top" style="padding-left: 0.0px; text-align: center; width: 40%">
          <p style="margin-top: 0px; margin-bottom: 0px">
            (Commission File No.)
          </p>
        </td>
        <td style="width: 20%">

        </td>
        <td valign="top" style="padding-left: 0.0px; text-align: center; width: 40%">
          <p style="margin-top: 0px; margin-bottom: 0px">
            (IRS Employer Identification
          </p>
        </td>
      </tr>
      <tr>
        <td valign="bottom" style="padding-left: 0.0px; text-align: center; width: 40%">
          <p style="margin-top: 0px; margin-bottom: 0px">
            &#160;
          </p>
        </td>
        <td style="width: 20%">

        </td>
        <td valign="bottom" style="padding-left: 0.0px; text-align: center; width: 40%">
          <p style="margin-top: 0px; margin-bottom: 0px">
            Number)
          </p>
        </td>
      </tr>
    </table>
    </div>
    <div style="text-align:center">
    <table cellspacing="0" style="font-size: 10pt; margin-left:auto;margin-right:auto; width: 100%; margin-bottom: 10.0px; font-family: Times New Roman">
      <tr>
        <td valign="bottom" style="padding-left: 0.0px; text-align: center">
          <p style="margin-top: 0px; margin-bottom: 0px">
            3838 West Parkway Boulevard<br>Salt Lake City, Utah 84120
          </p>
        </td>
      </tr>
      <tr>
        <td valign="bottom" style="padding-left: 0.0px; text-align: center">
          <p style="margin-top: 0px; margin-bottom: 0px">
            <font style="font-family: Times New Roman; font-size: 10pt">(Address
            of principal executive offices,</font> <font style="font-family: Times New Roman; font-size: 10pt">Zip
            Code)</font>
          </p>
        </td>
      </tr>
      <tr>
        <td valign="top" style="padding-left: 0.0px; text-align: center">
          <p style="font-size: 10pt; font-family: Times New Roman">
            <font style="font-family: Times New Roman; font-size: 10pt">Registrant&#8217;s
            telephone number, including area code: </font><font style="font-size: 10pt">(801)
            954-7100</font>
          </p>
        </td>
      </tr>
    </table>
    </div>
    <p style="text-align: center">
      <br>

    </p>
    <p>
      <font style="font-family: Times New Roman; font-size: 10pt">Check the
      appropriate box below if the Form 8-K filing is intended to
      simultaneously satisfy the filing obligation of the registrant under any
      of the following provisions:</font>
    </p>
    <p>
      <font style="font-family: Arial Unicode MS; font-size: 10pt">&#8414;</font>
      <font style="font-family: Times New Roman; font-size: 10pt">Written
      communications pursuant to Rule 425 under the Securities Act (17 CFR
      230.425)</font>
    </p>
    <p>
      <font style="font-family: Arial Unicode MS; font-size: 10pt">&#8414;</font>
      <font style="font-family: Times New Roman; font-size: 10pt">Soliciting
      material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
      240.14a-12)</font>
    </p>
    <p>
      <font style="font-family: Arial Unicode MS; font-size: 10pt">&#8414;</font>
      <font style="font-family: Times New Roman; font-size: 10pt">Pre-commencement
      communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
      240.14d-2(b))</font>
    </p>
    <p>
      <font style="font-family: Arial Unicode MS; font-size: 10pt">&#8414;</font>
      <font style="font-family: Times New Roman; font-size: 10pt">Pre-commencement
      communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
      240.13e-4(c))</font>
    </p>
<div style="text-align:left">
    <table cellspacing="0" style="font-size: 10pt; width: 100%; margin-bottom: 10.0px; font-family: Times New Roman">
      <tr>
        <td valign="top" style="padding-left: 0.0px; text-align: left; width: 5%">
          <p style="font-size: 10pt">
            <font style="font-family: Arial Unicode MS; font-size: 10pt">&#8414;</font>
          </p>
        </td>
        <td valign="top" style="padding-left: 0.0px; text-align: left; width: 95%">
          Indicate by check mark whether the registrant is an emerging growth
          company as defined in Rule 405 of the Securities Act of 1933 (17 CFR
          &#167;230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17
          CFR &#167;240.12b-2).
        </td>
      </tr>
    </table>
    </div>
<div style="text-align:left">
    <table cellspacing="0" style="font-size: 10pt; width: 100%; margin-bottom: 10.0px; font-family: Times New Roman">
      <tr>
        <td valign="top" style="padding-left: 0.0px; text-align: left; width: 5%">
          <p style="font-size: 10pt">
            <font style="font-family: Arial Unicode MS; font-size: 10pt">&#8414;</font>
          </p>
        </td>
        <td valign="top" style="padding-left: 0.0px; text-align: left; width: 95%">
          <p style="margin-top: 0px; margin-bottom: 0px">
            If an emerging growth company, indicate by check mark if the
            registrant has elected not to use the extended transition period
            for complying with any new or revised financial accounting
            standards provided pursuant to Section 13(a) of the Exchange Act.
          </p>
        </td>
      </tr>
    </table>
    </div>
    <p>

    </p>
    <div style="margin-right: 0pt; text-indent: 0pt; width: 100%; margin-bottom: 10pt; margin-left: 0pt">
      <div>
        <div style="text-align: left">

        </div>
      </div>
      <div style="page-break-after: always">
        <div style="text-align: center">

        </div>
        <div style="text-align: center">
          <hr style="color: black; height: 1.5pt">

        </div>
      </div>
      <div>
        <div style="text-align: right">

        </div>
      </div>
    </div>
    <p>

    </p>
<div style="text-align:left">
    <table cellspacing="0" style="font-size: 10pt; width: 100%; margin-bottom: 10.0px; font-family: Times New Roman">
      <tr>
        <td valign="top" style="padding-left: 0.0px; text-align: left; width: 10%">
          <p style="margin-top: 0px; margin-bottom: 0px">
            <b>Item 5.02.</b>
          </p>
        </td>
        <td valign="top" style="padding-left: 0.0px; text-align: left; width: 2%">
          &#160;
        </td>
        <td valign="top" style="padding-left: 0.0px; text-align: left; width: 88%">
          <p style="margin-top: 0px; margin-bottom: 0px">
            <b>Departure of Directors or Principal Officers; Election of
            Directors; Appointment of Principal Officers.</b>
          </p>
        </td>
      </tr>
    </table>
    </div>
    <p>

    </p>
    <p>
      Effective as of December 19, 2018, the Board of Directors of USANA
      Health Sciences, Inc. (the &#8220;Company&#8221;) acted unanimously to appoint Ms.
      Peggie Pelosi as an additional director of the Company, for an initial
      term expiring at the Company&#8217;s 2019 Annual Meeting of Shareholders. Ms.
      Pelosi has not been appointed to any Committees of the Board of
      Directors at this time.
    </p>
    <p>
      Ms. Pelosi is a corporate social responsibility/sustainability
      practitioner. Since 2005, Ms. Pelosi has been the founding partner and
      strategic advisor at Orenda Connections, a corporate social
      responsibility consultancy in Toronto, Ontario, Canada. She is also an
      Instructor in the Certificate Program in corporate social responsibility
      at the University of St. Michael's College in the University of Toronto,
      and a part-time professor in sustainable business management post
      graduate studies at Seneca College, Faculty of Business in Toronto.
      Since 2015, she has also served as the Executive Director of Innovators
      Alliance, a network of CEO&#8217;s focused on sustainable and profitable
      growth through innovation.
    </p>
    <p>
      Prior to her career and academic work in corporate social responsibility
      and sustainability, Ms. Pelosi served as a member of the Company&#8217;s
      management team, first as Executive Director of Sales for Canada and
      then as Vice President of Network Development. She worked for the
      Company until 2004. While at the Company, Ms. Pelosi began the program
      that would evolve into the USANA True Health Foundation, and this led to
      her interest in corporate social responsibility. Prior to her roles at
      the Company, Ms. Pelosi had 15 years of direct selling leadership
      experience. Ms. Pelosi has also previously served on the Board of
      Directors of a number on non-profit organizations including the
      Children&#8217;s Hunger Fund and Big Brothers Big Sisters of Toronto.
    </p>
<div style="text-align:left">
    <table cellspacing="0" style="font-size: 10pt; width: 100%; margin-bottom: 10.0px; font-family: Times New Roman">
      <tr>
        <td valign="top" style="padding-left: 0.0px; text-align: left; width: 10%">
          <p style="margin-top: 0px; margin-bottom: 0px">
            <b>Item 9.01.</b>
          </p>
        </td>
        <td valign="top" style="padding-left: 0.0px; text-align: left; width: 2%">
          &#160;
        </td>
        <td valign="top" style="padding-left: 0.0px; text-align: left; width: 88%">
          <p style="margin-top: 0px; margin-bottom: 0px">
            <b>Financial Statements and Exhibits.</b>
          </p>
        </td>
      </tr>
      <tr>
        <td style="width: 10%">

        </td>
        <td style="width: 2%">

        </td>
        <td style="width: 88%">
          &#160;
        </td>
      </tr>
      <tr>
        <td valign="top" style="padding-left: 0.0px; text-align: left; width: 10%">

        </td>
        <td valign="top" style="padding-left: 0.0px; text-align: left; width: 2%">

        </td>
        <td valign="top" style="padding-left: 0.0px; text-align: left; width: 88%">
          (d) Exhibits
        </td>
      </tr>
      <tr>
        <td style="width: 10%">

        </td>
        <td style="width: 2%">

        </td>
        <td style="width: 88%">
          &#160;
        </td>
      </tr>
      <tr>
        <td valign="top" style="padding-left: 0.0px; text-align: left; width: 10%">
          <p style="margin-top: 0px; margin-bottom: 0px">
            <a href="a51916885ex99_1.htm">Exhibit 99.1</a>
          </p>
        </td>
        <td valign="top" style="padding-left: 0.0px; text-align: left; width: 2%">

        </td>
        <td valign="top" style="padding-left: 0.0px; text-align: left; width: 88%">
          <p style="margin-top: 0px; margin-bottom: 0px">
            <a href="a51916885ex99_1.htm">Press release issued by USANA Health
            Sciences, Inc. dated December 19, 2018 (furnished herewith).</a>
          </p>
        </td>
      </tr>
    </table>
    </div>
    <p style="white-space: nowrap">

    </p>
    <div style="margin-right: 0pt; text-indent: 0pt; width: 100%; margin-bottom: 10pt; margin-left: 0pt">
      <div>
        <div style="text-align: left">

        </div>
      </div>
      <div style="page-break-after: always">
        <div style="text-align: center">

        </div>
        <div style="text-align: center">
          <hr style="color: black; height: 1.5pt">

        </div>
      </div>
      <div>
        <div style="text-align: right">

        </div>
      </div>
    </div>
    <p>

    </p>
    <p style="text-align: center">
      <br>
      <font style="font-family: Times New Roman; font-size: 10pt"><b>SIGNATURES</b></font><br>
    </p>
    <p>
      Pursuant to the requirements of the Securities Exchange Act of 1934, the
      registrant has duly caused this report to be signed on its behalf by the
      undersigned hereunto duly authorized.
    </p>
    <p style="text-align: justify; text-indent: 30.0px">

    </p>
<div style="text-align:left">
    <table cellspacing="0" style="font-size: 10pt; width: 100%; margin-bottom: 10.0px; font-family: Times New Roman">
      <tr>
        <td style="width: 5%">

        </td>
        <td style="width: 52%">

        </td>
        <td valign="top" style="padding-left: 0.0px; text-align: left" colspan="2">
          <p style="margin-top: 0px; margin-bottom: 0px">
            <b>USANA HEALTH SCIENCES, INC.</b>
          </p>
        </td>
        <td style="width: 15%">

        </td>
      </tr>
      <tr>
        <td style="width: 5%">

        </td>
        <td style="width: 52%">

        </td>
        <td style="width: 3%">

        </td>
        <td valign="top" style="padding-left: 0.0px; text-align: left; width: 25%">
          <p style="margin-top: 0px; margin-bottom: 0px">
            &#160;
          </p>
        </td>
        <td style="width: 15%">

        </td>
      </tr>
      <tr>
        <td style="width: 5%">

        </td>
        <td style="width: 52%">

        </td>
        <td style="width: 3%">

        </td>
        <td valign="top" style="padding-left: 0.0px; text-align: left; width: 25%">
          <p style="margin-top: 0px; margin-bottom: 0px">
            &#160;
          </p>
        </td>
        <td style="width: 15%">

        </td>
      </tr>
      <tr>
        <td valign="top" style="padding-left: 0.0px; padding-bottom: 2.0px; text-align: left; width: 5%">
          <p style="margin-top: 0px; margin-bottom: 0px">
            &#160;
          </p>
        </td>
        <td valign="top" style="padding-left: 0.0px; padding-bottom: 2.0px; text-align: left; width: 52%">
          <p style="margin-top: 0px; margin-bottom: 0px">
            &#160;
          </p>
        </td>
        <td valign="top" style="padding-left: 0.0px; padding-bottom: 2.0px; text-align: left; width: 3%">
          <p style="margin-top: 0px; margin-bottom: 0px">
            <b>By:</b>
          </p>
        </td>
        <td valign="top" style="padding-left: 0.0px; border-bottom-width: 1.0pt; border-bottom-style: solid; text-align: left; width: 25%; border-bottom-color: black">
          <p style="margin-top: 0px; margin-bottom: 0px">
            /s/ G. Douglas Hekking
          </p>
        </td>
        <td style="width: 15%">

        </td>
      </tr>
      <tr>
        <td style="width: 5%">

        </td>
        <td style="width: 52%">

        </td>
        <td style="width: 3%">

        </td>
        <td valign="top" style="padding-left: 0.0px; text-align: left" colspan="2">
          <p style="margin-top: 0px; margin-bottom: 0px">
            G. Douglas Hekking, Chief Financial Officer
          </p>
        </td>
      </tr>
      <tr>
        <td style="width: 5%">

        </td>
        <td style="width: 52%">

        </td>
        <td style="width: 3%">

        </td>
        <td valign="top" style="padding-left: 0.0px; text-align: left; width: 25%">
          <p style="margin-top: 0px; margin-bottom: 0px">
            &#160;
          </p>
        </td>
        <td style="width: 15%">

        </td>
      </tr>
      <tr>
        <td style="width: 5%">

        </td>
        <td style="width: 52%">

        </td>
        <td style="width: 3%">

        </td>
        <td style="width: 25%">

        </td>
        <td style="width: 15%">
          &#160;
        </td>
      </tr>
      <tr>
        <td valign="top" style="padding-left: 0.0px; text-align: left; width: 5%">
          <p style="margin-top: 0px; margin-bottom: 0px">
            Date:
          </p>
        </td>
        <td valign="top" style="padding-left: 0.0px; text-align: left; width: 52%">
          <p style="margin-top: 0px; margin-bottom: 0px">
            December 19, 2018
          </p>
        </td>
        <td style="width: 3%">

        </td>
        <td style="width: 25%">

        </td>
        <td style="width: 15%">

        </td>
      </tr>
    </table>
    </div>
    <p>

    </p>
    <p>

    </p>
  </body>
</html>
<!--<!DOCTYPE html
     PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN"
     "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd">-->
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>a51916885ex99_1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
  <head>
    <title></title>
<!--Copyright 2018 Business Wire, a Berkshire Hathaway company.-->
<!--All rights reserved www.businesswire.com-->
  </head>
  <body style="font-family: Times New Roman; font-size: 8pt">
    <p style="text-align: right">
      <b>Exhibit 99.1</b>
    </p>
    <p style="text-align: center">
      <font style="font-size: 12pt; font-family: Times New Roman"><b>USANA
      Health Sciences Announces Appointment of Peggie Pelosi to Board of
      Directors</b></font>
    </p>
    <p style="text-align: center">

    </p>
    <p>
      SALT LAKE CITY--(BUSINESS WIRE)--December 19, 2018--USANA Health
      Sciences, Inc. (NYSE: USNA) today announced the appointment of Peggie
      Pelosi to the company&#8217;s board of directors effective December 19, 2018.
      Ms. Pelosi joins the board as an independent director and brings
      expertise in corporate social responsibility and sustainability, as well
      as direct selling. The USANA board now has eight members, five of whom
      are independent.
    </p>
    <p>
      Myron W. Wentz, Ph.D., Chairman of the Board, commented, &#8220;I&#8217;m very
      pleased to welcome Peggie Pelosi to our board. Her significant expertise
      in corporate social responsibility and sustainability, combined with
      more than two decades of direct selling experience, make her an
      excellent addition as an independent director. I look forward to the
      contributions she will make to the Board and USANA.&#8221;
    </p>
    <p>
      Ms. Pelosi commented, &#8220;I am honored to accept a seat on the board of
      directors for a company with such strong corporate values. Having spent
      five years as an employee of USANA, I am very familiar with the
      company&#8217;s business. Although it has grown significantly since then, the
      company has maintained its commitment to its vision and continues to be
      a leader in its industry. I look forward to contributing to USANA&#8217;s
      future success.&#8221;
    </p>
    <div style="margin-right: 0pt; text-indent: 0pt; width: 100%; margin-bottom: 10pt; margin-left: 0pt">
      <div>
        <div style="text-align: left">

        </div>
      </div>
      <div style="page-break-after: always">
        <div style="text-align: center">

        </div>
        <div style="text-align: center">
          <hr style="color: black; height: 1.5pt">

        </div>
      </div>
      <div>
        <div style="text-align: right">

        </div>
      </div>
    </div>
    <p>
      <b>About Peggie Pelosi</b>
    </p>
    <p>
      Ms. Pelosi is a corporate social responsibility/sustainability
      practitioner. Since 2005, Ms. Pelosi has been the Founding Partner and
      Strategic Advisor at Orenda Connections, a corporate social
      responsibility consultancy in Toronto, Ontario, Canada. She is also an
      Instructor in the Certificate Program in Corporate Social Responsibility
      at the University of St. Michael's College in the University of Toronto,
      and a part-time Professor in Sustainable Business Management Post
      Graduate Studies at Seneca College, Faculty of Business in Toronto.
      Since 2015, she has also served as the Executive Director of Innovators
      Alliance, a network of CEOs focused on sustainable and profitable growth
      through innovation.
    </p>
    <p>
      Prior to her career and academic work in corporate social responsibility
      and sustainability, Ms. Pelosi served as a member of the Company&#8217;s
      management team, first as Executive Director of Sales for Canada and
      then as Vice President of Network Development. She worked for the
      Company until 2004. While at the Company, Ms. Pelosi began the program
      that would evolve into the USANA True Health Foundation, and this led to
      her interest in corporate social responsibility. Prior to her roles at
      the Company, Ms. Pelosi had 15 years of direct selling leadership
      experience. Ms. Pelosi has also previously served on the Board of
      Directors of a number on non-profit organizations including the
      Children&#8217;s Hunger Fund and Big Brothers Big Sisters of Toronto. She is a
      graduate of the CSR program at St. Michael&#8217;s College at the University
      of Toronto.
    </p>
    <p>
      <b>About USANA</b>
    </p>
    <p>
      USANA develops and manufactures high-quality nutritional supplements,
      healthy foods and personal care products that are sold directly to
      Associates and Preferred Customers throughout the United States, Canada,
      Australia, New Zealand, Hong Kong, China, Japan, Taiwan, South Korea,
      Singapore, Mexico, Malaysia, the Philippines, the Netherlands, the
      United Kingdom, Thailand, France, Belgium, Colombia, Indonesia, Germany,
      Spain, Romania, and Italy. More information on USANA can be found at <u>www.usana.com</u>.
    </p>
    <p>
      CONTACT:<br>Investors contact:<br>Patrique Richards<br>Investor Relations<br>(801)
      954-7961<br><u>investor.relations@us.usana.com</u>
    </p>
    <p>
      Media contact:<br>Dan Macuga<br>Public Relations<br>(801) 954-7280
    </p>
    <p style="white-space: nowrap">

    </p>
  </body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
